ClinicalTrials.gov
public full text
Public Domain
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
This is a Phase 2a study to investigate the efficacy, safety, tolerability, PK, and PD of ATI-450 versus placebo in patients with moderate to severe psoriatic arthritis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis#1419615
- Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study#968921
- Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis#902711
- Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies.#193416
- Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis#1127694
Record · ID 1486678
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive